Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. Gemmen is active.

Publication


Featured researches published by E. Gemmen.


Clinical Infectious Diseases | 2007

National Trends in Staphylococcus aureus Infection Rates: Impact on Economic Burden and Mortality over a 6-Year Period (1998–2003)

Gary A. Noskin; Robert J. Rubin; Jerome J. Schentag; Jan Kluytmans; Edwin C. Hedblom; Cassie Jacobson; Maartje Smulders; E. Gemmen; Murtuza Bharmal

BACKGROUND We evaluated historical trends in the Staphylococcus aureus infection rate, economic burden, and mortality in US hospitals from 1998 through 2003. METHODS The Nationwide Inpatient Sample was used to assess trends over time of S. aureus infection during 1998-2003. Historical trends were determined for 5 strata of hospital stays, including all inpatient stays, surgical procedure stays, invasive cardiovascular surgical stays, invasive orthopedic surgical stays, and invasive neurosurgical stays. RESULTS During the 6-year study period from 1998 through 2003, the rate of S. aureus infection increased significantly for all inpatient stays (from 0.74% to 1.0%; annual percentage change (APC), 7.1%; P=.004), surgical stays (from 0.90% to 1.3%; APC, 7.9%; P=.001), and invasive orthopedic surgical stays (from 1.2% to 1.8%; APC, 9.3%; P<.001). For invasive neurosurgical stays, the rate of S. aureus infection did not change from 1998 to 2000 but increased at an annual rate of 11.0% from 2000 to 2003 (from 1.4% to 1.8%; P=.034). The total economic burden of S. aureus infection for hospitals also increased significantly for all stay types, with the annual percentage increase ranging from 9.2% to 17.9% (P<.05 for all). In 2003, the total economic burden of S. aureus infection was estimated to be


Infection Control and Hospital Epidemiology | 2008

Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals .

Gary A. Noskin; Robert J. Rubin; Jerome J. Schentag; Jan Kluytmans; Edwin C. Hedblom; Cassie Jacobson; Maartje Smulders; E. Gemmen; Murtuza Bharmal

14.5 billion for all inpatient stays and


PharmacoEconomics | 2009

Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study.

Laura T. Pizzi; Amy Talati; E. Gemmen; Naomi V. Dahl; Thomas J. Bunz; Peter K. Sand

12.3 billion for surgical patient stays. However, there were significant decreases in the risk of S. aureus-related in-hospital mortality from 1998 to 2003 for all inpatient stays (from 7.1% to 5.6%; APC, -4.6%; P=.001) and for surgical stays (from 7.1% to 5.5%; APC, -4.6%; P=.002). CONCLUSIONS The inpatient S. aureus infection rate and economic burden of S. aureus infections for US hospitals increased substantially from 1998 to 2003, whereas the in-hospital mortality rate decreased.


Journal of Medical Economics | 2008

Resource utilisation, charges and mortality following hospital inpatient admission for congestive heart failure among the elderly in the US.

Murtuza Bharmal; E. Gemmen; Teresa Zyczynski; Andrew Linnstaedt; David Kenny; Claudio Marelli

OBJECTIVE To evaluate the economic impact of performing rapid testing for Staphylococcus aureus colonization before admission for all inpatients who are scheduled to undergo elective surgery and providing subsequent decolonization therapy for those patients found to be colonized with S. aureus. METHODS A budget impact model that used probabilistic sensitivity analysis to account for the uncertainties in the input variables was developed. Primary input variables included the marginal effect of S. aureus infection on patient outcomes among patients who underwent elective surgery, patient demographic characteristics, the prevalence of nasal carriage of S. aureus, the sensitivity and specificity of the rapid diagnostic test for S. aureus colonization, the efficacy of decolonization therapy for nasal carriage of S. aureus, and cost data. Data sources for the input variables included the 2003 Nationwide Inpatient Sample data and the published literature. RESULTS In 2003, there were an estimated 7,181,484 patients admitted to US hospitals for elective surgery. Our analysis indicated preadmission testing and subsequent decolonization therapy for patients colonized with S. aureus would have produced a mean annual cost savings to US hospitals of


Postgraduate Medicine | 2013

A Practice-Based Research Network Focused on Comparative Effectiveness Research in Type 2 Diabetes Management

John E. Anderson; Andrew S Rhinehart; Timothy Reid; Robert Cuddihy; Aleksandra Vlajnic; Mehul Dalal; E. Gemmen; Bryan Johnstone; Babak Abbaszadeh; Josh Reed; Jennifer Sheller; John Stewart; Essy Mozaffari

231,538,400 (95% confidence interval [CI], -


Annals of the Rheumatic Diseases | 2013

FRI0443 Impact of etanercept therapy on disease activity and health-related quality of life of a moderate rheumatoid arthritis patient population from a national british observational cohort

Sameer Kotak; Jack Mardekian; N. Horowicz-Mehler; Ankit Shah; A.J. Burgess; J. Kim; E. Gemmen; Helen Boyd; Andrew S. Koenig

300 million to


Value in Health | 2010

PRS19 ASSESSMENT OF THE CLINICAL AND ECONOMIC IMPACT OF AIR LEAKS DURING POST-OPERATIVE PULMONARY SURGERY USING THE MEDICARE POPULATION

E. Gemmen; J Doyle; Bf Smith; W Garvert; J Proach; J Long; Mp Nagel

1.3 billion). The mean annual number of hospital-days that could have been eliminated was estimated at 364,919 days (95% CI, 67,893-926,983 days), and a mean of 935 in-hospital deaths (95% CI, 88-3,691) could have been avoided per year. Sensitivity analysis indicated a 64.5% probability that there would be cost savings to US hospitals as a result of preadmission testing and subsequent decolonization therapy. CONCLUSION The addition of preadmission testing and decolonization therapy to standard care would result in significant cost savings, even after accounting for variations in the model input values.


Value in Health | 2010

PMC24 LAST OBSERVATION CARRIED FORWARD (LOCF) VS. MIXED-EFFECTS MODEL REPEATED MEASURES (MMRM): EMPIRICAL EVALUATION OF TWO APPROACHES TO ANALYZING LONGITUDINAL DATA WITH MISSING OBSERVATIONS

H Jo; E. Gemmen; M Bharmal

AbstractBackground: Overactive bladder syndrome (OAB) is a common condition affecting a significant number of working adults, resulting in increased healthcare utilization, reduced quality of life and decreased work productivity. The MATRIX study was a large, prospective, community-based, observational US study aimed at evaluating the impact of oxybutynin transdermal system (OXY-TDS). In this paper, we report on productivity findings among working adults in MATRIX. Methods: This study enrolled 2878 adults (aged ≥18 years) with symptoms of OAB from 327 practice sites throughout the US. All subjects received OXY-TDS (3.9 mg/day up to 6 months). Baseline versus end-of-study productivity was measured using the Work Productivity Questionnaire (WPQ). The WPQ includes a subset of questions from the Work Limitations Questionnaire (WLQ) and consists of four scales: (i) physical; (ii) time management; (iii) mental; and (iv) output demands. Overall productivity was measured by the work productivity index score (WPQ Index; a summary score based on scales) and work productivity loss score (WPLS; a measure of reduced output compared with healthy workers). Psychometric performance of the WPQ instrument is also reported, since this study represents the first use of the tool. Results: Of the participants, 52% were of working age (18–65 years) and 38.6% were employed. A total of 1112 working adults participated in MATRIX and were included in this analysis. They had a mean age of 52.4 years; 92.2% were female and 80.9% were Caucasian. Subjects who reported that they were most affected by OAB were also most impaired at work. After OXY-TDS treatment, participants experienced significant improvements in mean scores for all four WPQ scales (p ≤0.0002) and the mean WPQ Index decreased from 8.2 to 5.5 (p < 0.0001). In addition, the WPLS decreased from 7.7% to 5.2% (p < 0.0001), indicating improvement in work function with OXY-TDS treatment. Conclusion: OAB contributes to decreased work productivity due to job interruptions as well as fatigue. OXY-TDS may result in productivity improvement when patients receive 3.9 mg/day via twice weekly patch application for up to 6 months.


Value in Health | 2007

PCV20 EVALUATING GENDER DIFFERENCES IN HEALTH CARE RESOURCE USE AND OUTCOMES AMONG ELDERLY PATIENTS WITH CONGESTIVE HEART FAILURE

Murtuza Bharmal; T Zyczynski; A Linnstaedt; L Kennedy; E. Gemmen

Abstract Objectives: This study examined resource utilisation, charges and mortality among congestive heart failure (CHF) patients over the course of the first year following initial hospital discharge for CHF in the US. Methods: The Medicare Standard Analytic Files for the years 1998 through to 2001 were used for the analysis. The study sample included patients with an inpatient hospitalisation between the 1st January 1999 and the 31st December 2000 with a primary ICD-9 diagnosis code of CHF. Statistical analysis including univariate and multivariate regression analysis were conducted. Results: Within 1 year following initial CHF discharge, 50% of patients had at least one all-cause readmission and 20% had at least one CHF-related readmission. The mean total charges among all patients was


Value in Health | 2006

PR6 VALIDATION OF THE WORK PRODUCTIVITY QUESTIONNAIRE: RESULTS OF THE MATRIX STUDY

Ar Talati; Laura T. Pizzi; N Dahl; E. Gemmen

36,230 (sd

Collaboration


Dive into the E. Gemmen's collaboration.

Top Co-Authors

Avatar

Laura T. Pizzi

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Kluytmans

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mehul Dalal

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge